Concord Biotech Statistics

Total Valuation

Concord Biotech has a market cap or net worth of INR 172.64 billion. The enterprise value is 169.83 billion.

Market Cap	172.64B
Enterprise Value	169.83B

Important Dates

The last earnings date was Monday, February 10, 2025.

Earnings Date	Feb 10, 2025
Ex-Dividend Date	n/a

Share Statistics

Concord Biotech has 104.62 million shares outstanding. The number of shares has increased by 0.01% in one year.

Current Share Class	n/a
Shares Outstanding	104.62M
Shares Change (YoY)	+0.01%
Shares Change (QoQ)	-0.06%
Owned by Insiders (%)	70.53%
Owned by Institutions (%)	15.36%
Float	16.52M

Valuation Ratios

The trailing PE ratio is 52.91 and the forward PE ratio is 40.78. Concord Biotech's PEG ratio is 1.72.

PE Ratio	52.91
Forward PE	40.78
PS Ratio	15.85
PB Ratio	10.86
P/TBV Ratio	10.86
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	1.72

Financial Ratio History

Enterprise Valuation

EV / Earnings	52.05
EV / Sales	15.59
EV / EBITDA	37.21
EV / EBIT	42.08
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	0.00
Debt / EBITDA	0.01
Debt / FCF	n/a
Interest Coverage	452.29

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	17.06%
Return on Capital Employed (ROCE)	n/a
Revenue Per Employee	7.91M
Profits Per Employee	2.37M
Employee Count	1,377
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +18.95% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+18.95%
50-Day Moving Average	2,111.32
200-Day Moving Average	1,854.45
Relative Strength Index (RSI)	28.78
Average Volume (20 Days)	249,540

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Concord Biotech had revenue of INR 10.89 billion and earned 3.26 billion in profits. Earnings per share was 31.19.

Revenue	10.89B
Gross Profit	8.05B
Operating Income	4.06B
Pretax Income	4.40B
Net Income	3.26B
EBITDA	4.57B
EBIT	4.06B
Earnings Per Share (EPS)	31.19

Full Income Statement

Balance Sheet

The company has 2.84 billion in cash and 34.24 million in debt, giving a net cash position of 2.80 billion or 26.79 per share.

Cash & Cash Equivalents	2.84B
Total Debt	34.24M
Net Cash	2.80B
Net Cash Per Share	26.79
Equity (Book Value)	15.90B
Book Value Per Share	151.99
Working Capital	n/a

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 73.90%, with operating and profit margins of 37.23% and 29.96%.

Gross Margin	73.90%
Operating Margin	37.23%
Pretax Margin	40.37%
Profit Margin	29.96%
EBITDA Margin	41.93%
EBIT Margin	37.23%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 8.75, which amounts to a dividend yield of 0.53%.

Dividend Per Share	8.75
Dividend Yield	0.53%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	n/a
Buyback Yield	-0.01%
Shareholder Yield	0.52%
Earnings Yield	1.89%
FCF Yield	n/a

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a